Digestive System Diseases Unknown Status Phase 2 / 3 Trials for Mesalazine (DB00244)

Also known as: Digestive System Disease

IndicationStatusPhase
DBCOND0033030 (Digestive System Diseases)Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02044952Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction RemissionTreatment